Suchergebnisse - "Best, Jennie H"

PubPharm (37)

31

Risk of cardiovascular disease events in patients with type 2 diabetes prescribed the glucagon-like peptide 1 (GLP-1) receptor agonist exenatide twice daily or other glucose-lowering therapies : a retrospective analysis of the LifeLink database

enthalten in: Diabetes care | 2011

von Best, J. | Hoogwerf, B. | Herman, W. | +4

32

Patient reported outcomes in adults with type 2 diabetes on basal insulin randomized to addition of mealtime pramlintide or rapid-acting insulin analogs

enthalten in: Current medical research and opinion | 2010

von Peyrot, M. | Rubin, R. | Polonsky, W. | +1

33

Preference values associated with stage III colon cancer and adjuvant chemotherapy

enthalten in: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation | 2010

von Best, J. | Garrison, L. | Hollingworth, W. | +2

34

Economic evaluation of capecitabine as adjuvant or metastatic therapy in colorectal cancer

enthalten in: Expert review of pharmacoeconomics & outcomes research | 2010

von Best, J. | Garrison, L.

35

The economic value of reducing medication dosing frequency with drug delivery technologies : an evidence assessment

enthalten in: Journal of medical economics | 2010

von Cheng, M. | Alfonso, R. | Best, J. | +3

36

Cost-effectiveness analysis of rituximab combined with chop for treatment of diffuse large B-cell lymphoma

enthalten in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | 2005

von Best, J. | Hornberger, J. | Proctor, S. | +2

37

Cost utility in the United States of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone for the treatment of elderly patients with diffuse large B-cell lymphoma

enthalten in: Cancer | 2005

von Hornberger, J. | Best, J.